BDB001-102: Open Label Dose Escalation of BDB001 in Combination w Atezolizumab
Clinical trial NCT04196530 · COMPLETED
Trial details
- NCT number
- NCT04196530
- Sponsor
- Eikon Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-21
- Primary completion
- 2024-07-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.